Table 6.

Clinical outcome dataa

aAbbreviations as in Table 1.
Follow-up available19 of 2479.2%
Mean follow-up time (months)30.6(range, 3 to 132)
Lithium discontinued20 of 2195.2%
End-stage renal disease8 of 1942.1%
SCr Initial <2.5 mg/dl (n = 10)SCr Initial >2.5 mg/dl (n = 9)
SCr declines >0.4 mg/dl30
SCr rises or declines <0.5 mg/dl61
SCr rises >0.4 mg/dl (or ESRD)18